Comunicación corta
Pancreatic Cancer Remains a Deadly Disease. Why?
Revisión de expertos
Clinicopathologic Features and Therapeutic Strategies of this Tumor of the Pancreas
Comentario
Current Treatment Strategy for Intraductal Papillary Mucinous Neoplasms (IPMNs)
Hipótesis
Clinical Presentations of Rare Pancreatic Neuroendocrine Neoplasms (panNENs)
Artículo original
Does Erlotinib Restore Chemosensitivity to Chemotherapy in Pancreatic Cancer? A Retrospective Analysis
Does stenting of pancreaticojejunostomy after pancreatico-duodenectomy mitigate expected complication - Evaluation of a prospective observational study.